SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-08
👔
Damora Therapeutics, Inc.
@DMRA_InsiderForm 4 Filing: Winslow Garrett Sells $7,345.1 of $DMRA
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
Damora Therapeutics, Inc.
Ticker: $DMRA
Transaction Value
$7,345.1
Price/Share: $7.94
transaction date
2026-07-06
Shares: 925
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Winslow Garrett, holds the title of General Counsel at Damora Therapeutics, Inc..
On 2026-07-06, the insider transacted 925 shares.The shares were transacted at a weighted average price of $7.94 per share, resulting in a total market-relevant value of $7,345.1.
Executive Summary Summary
Winslow Garrett (General Counsel) sold $7K of $DMRA
Post-Transaction Position: 2,289 shares
SEC Accession No: 0001193125-26-297818 (CIK: 1803773)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.